MIRODERM H2H DFU Study

CompletedOBSERVATIONAL
Enrollment

53

Participants

Timeline

Start Date

July 21, 2017

Primary Completion Date

September 20, 2018

Study Completion Date

September 20, 2018

Conditions
Diabetic Foot Ulcer
Interventions
DEVICE

Biologic wound graft

Diabetic foot ulcer will be treated by grafting with MIRODERM Biologic Wound Matrix

Trial Locations (9)

10010

Gramercy Park Podiatry, New York

10022

Foot Associates of New York, New York

10550

A Step Ahead Foot Care, Mount Vernon

33880

Bond Clinic / Clinical Reseach of Central Florida, Winter Haven

46123

American Health Network, Avon

63128

St. Anthony's Wound Care Center, St Louis

66125

Kansas City Institute of Podiatry, Overland Park

84770

Foot and Ankle Institute, St. George

92009

ILD Research, Carlsbad

Sponsors
All Listed Sponsors
lead

Miromatrix Medical Inc.

INDUSTRY